EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

Mark P Hamilton, Takeshi Sugio iD, Troy Noordenbos, Shuyu Shi, Philip L Bulterys, Chih Long Liu, Xiaoman Kang, Mari N Olsen, Zinaida Good, Saurabh Dahiya, Matthew J Frank, Bita Sahaf und 5 weitere

New England Journal of Medicine · 13.06.2024 · 390 (22) · 2047-2060

DOI: 10.1056/nejmoa2401361 ↗

Kurz gefasst

Fallbericht in der Zeitschrift New England Journal of Medicine, erschienen am 13.06.2024. Verfasst von Mark P Hamilton und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Divisions of Oncology (M.P.H., T.S., T.N., C.L.L., X.K., M.N.O., A.A.A.) and Blood and Marrow Transplantation and Cellular Therapy (M.P.H., …. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Neoplasms, Second Primary. Die Arbeit wurde bisher 225-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, Leukemia and Lymphoma Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveLymphoma, Large B-Cell, DiffuseLymphoma, T-CellNeoplasms, Second PrimaryReceptors, Chimeric AntigenAntineoplastic Agents, ImmunologicalFemaleHumansMiddle AgedBiological ProductsClonal HematopoiesisHerpesvirus 4, HumanVirus Integration

Substanzen

axicabtagene ciloleucelBiological ProductsReceptors, Chimeric AntigenAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • From the Divisions of Oncology (M.P.H., T.S., T.N., C.L.L., X.K., M.N.O., A.A.A.) and Blood and Marrow Transplantation and Cellular Therapy (M.P.H., S.D., M.J.F., D.B.M.), Department of Medicine, the Center for Cancer C…

ORCID-Profile: Takeshi Sugio, Crystal L Mackall, Ash A Alizadeh

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Leukemia and Lymphoma Society
  • National Institutes of Health

Zitieren

APA

Hamilton, M. P., Sugio, T., Noordenbos, T., Shi, S., Bulterys, P. L., Liu, C. L., Kang, X., Olsen, M. N., Good, Z., Dahiya, S., Frank, M. J., Sahaf, B., Mackall, C. L., Gratzinger, D., Diehn, M., Alizadeh, A. A., & Miklos, D. B. (2024). Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. New England Journal of Medicine, 390(22), 2047-2060. https://doi.org/10.1056/nejmoa2401361

Vancouver

Hamilton MP, Sugio T, Noordenbos T, Shi S, Bulterys PL, Liu CL, et al. Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. New England Journal of Medicine. 2024;390(22):2047-2060. doi:10.1056/nejmoa2401361

BibTeX
@article{Hamilton2024,
  author = {Hamilton, Mark P and Sugio, Takeshi and Noordenbos, Troy and Shi, Shuyu and Bulterys, Philip L and Liu, Chih Long and Kang, Xiaoman and Olsen, Mari N and Good, Zinaida and Dahiya, Saurabh and Frank, Matthew J and Sahaf, Bita and Mackall, Crystal L and Gratzinger, Dita and Diehn, Maximilian and Alizadeh, Ash A and Miklos, David B},
  title = {Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {22},
  pages = {2047--2060},
  doi = {10.1056/nejmoa2401361}
}
Kostenlos starten →